[Not Available].

doi:10.1016/S0007-4551(16)30143-6

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[Not Available].

Bulletin du cancer - 1 Jun 2016

Soret Juliette, Kiladjian Jean-Jacques

Abstract excerpt

THE ROLE OF RUXOLITINIB IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS: The discovery of the JAK2V617F mutation in 2005, present in 95% of polycythemia vera (PV) and in 55% of myelofibrosis (MF) patients, opened the way for a new era of targeted therapies for myeloproliferative neoplasms. Ruxolitinib was the first-in-class Janus Kinase (JAK) inhibitor approved for the management of these diseases. In PV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase I as Topic
Share to Clinical Trials, Phase II as Topic
Share to Clinical Trials, Phase III as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Nitriles

Share to Palliative Care

Share to Pyrazoles

Source

Open in PubMed

Identifiers

PMID: 27494970
DOI: 10.1016/S0007-4551(16)30143-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Not Available].PMID 27494970Read ↗

[Not Available].Semantic proximity Read ↗

[No available].Semantic proximity Read ↗

Polycythemia Vera: Rapid Evidence Review.Semantic proximity Read ↗

[Not Available].Semantic proximity Read ↗

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosisSemantic proximity Read ↗

first authorSemantic proximity Read ↗

Clinically significant? Depends on whom you ask.Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.